Scopolamine effects on the pressor response to thyrotropin-releasing hormone in humans

Susan E. Molchan, James L. Hill, Marcia Minichiello, Benedetto Vitiello, Trey Sunderland

Research output: Contribution to journalArticlepeer-review

Abstract

Thyrotropin-releasing hormone (TRH) produces a marked pressor effect, which may be mediated by central cholinergic neurons, which in turn enhance sympathetic nervous system activity. In this study, 22 subjects (10 patients with Alzheimer's disease and 12 elderly controls) were administered IV scopolamine or placebo prior to administration of IV high-dose TRH (0.5 mg/kg). Systolic blood pressure was less on the day scopolamine was administered prior to TRH administration, as compared with placebo (F[1,20]=6.12, p<0.02). Results indicate that the pressor effect of TRH is attenuated by scopolamine, indicating a role of the cholinergic system in this response in humans.

Original languageEnglish (US)
Pages (from-to)933-938
Number of pages6
JournalLife Sciences
Volume54
Issue number13
DOIs
StatePublished - 1994

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Fingerprint Dive into the research topics of 'Scopolamine effects on the pressor response to thyrotropin-releasing hormone in humans'. Together they form a unique fingerprint.

Cite this